Fresenius Medical Care's shares fell 5% on Tuesday, despite upbeat quarterly results and higher 2024 guidance, with analysts highlighting a weak outlook for patient volumes.
Among older adults with normal blood pressure, replacing table salt with salt substitute reduced the incidence of hypertension vs a usual salt group, in the DECIDE-Salt trial.